Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-047253)

Filing Details

Accession Number:: 0001104659-21-047253
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-04-06 21:56:16
Reporting Period:: 2021-04-05

Accepted Time:: 2021-04-06 21:56:16
Original Submission Date:: 2021-04-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1818844	Virios Therapeutics Inc.	VIRI	Pharmaceutical Preparations (2834)	854314201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1831127	Scott Gregory Duncan	C/O Virios Therapeutics, Inc. 44 Milton Avenue Alpharetta GA 30009	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-05	15,675	$6.17	19,579	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.